Dr Barbara Fielding


Reader in Nutritional Sciences
BSc MPhil PhD RNutr
+44 (0)1483 688649
31 PG 00
Tues-Thurs

Biography

University roles and responsibilities

  • Programme Leader for MSc Nutritional Medicine

    Affiliations and memberships

    British Journal of Nutrition
    Reviews and Horizons Editor

    Research

    Research interests

    Indicators of esteem

    • In 2010, I was awarded the Cuthbertson Medal by the Nutrition Society for my work in human nutrition and metabolism.

      My teaching

      My publications

      Publications

      Scope: Fructose exacerbates post-prandial hypertriacylglycerolaemia. This may be partly due to increased enterocyte de novo lipogenesis (DNL). It is unknown whether this is concentration-dependent or whether fructose has a greater effect on lipid synthesis than glucose. The dose-dependent effects of fructose and glucose on DNL and de novo triacylglycerol (TAG)-glycerol synthesis were investigated in an enterocyte model; Caco-2 cells. Methods and results: Caco-2 cells were treated for 96h with 5mM, 25mM or 50mM fructose or glucose, or 12.5mM fructose/12.5mM glucose mix. DNL was measured following addition of [13C2]-acetate to apical media. In separate experiments, [13C6]-fructose and [13C6]-glucose were used to measure DNL and de novo TAG-glycerol synthesis. DNL from [13C2]-acetate was detected following all treatments, with greater amounts in intracellular than secreted (media) samples (all P

      BARBARA ANN FIELDING (2021)Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome, In: Metabolism, clinical and experimental125154908

      BACKGROUND Duodenal mucosal resurfacing (DMR) is a novel day-case endoscopic intervention which results in weight loss-independent reductions in HbA1c in patient with type 2 diabetes mellitus (T2DM). We hypothesized that DMR works by increasing insulin sensitivity and we aimed to investigate the mechanism of action of DMR through longitudinal metabolic phenotyping in humans. METHODSThirty-two insulin-resistant women with polycystic ovary syndrome (PCOS) and obesity were randomised in a double-blinded manner to DMR or sham endoscopy. They underwent measurements of insulin sensitivity using euglycaemic hyperinsulinaemic clamps, insulin secretion using oral glucose tolerance tests and reproductive function using weekly reproductive hormone profiles and ovarian ultrasonography for 6 months post-intervention. RESULTSA small increase in total body insulin sensitivity measured by the clamp was observed in both groups at week 12. An increase in insulin sensitivity, as measured by HOMA-IR, was observed in both groups at week 24. There was an increase in the number of menses (median 2 DMR, 0.5 sham). There were no significant differences between the two groups in these outcomes or insulin secretion. CONCLUSIONSThese findings suggest that DMR does not work by increasing insulin sensitivity in euglycaemic, insulin resistant women with PCOS. The procedure may exert its effects only in the context of hyperglycaemia or pathologically hyperplastic, insulin-desensitised duodenal mucosa.

      JOHANNA VON GERICHTEN, Annette L. West, Nicola A. Irvine, Elizabeth A. Miles, Philip C. Calder, Karen A. Lillycrop, BARBARA ANN FIELDING, Graham C. Burdge (2021)The partitioning of newly assimilated linoleic and α-linolenic acids between synthesis of longer-chain polyunsaturated fatty acids and hydroxyoctadecaenoic acids is a putative branch point in T cell essential fatty acid metabolism, In: Frontiers in Immunology12740749 Frontiers Media

      Longer chain polyunsaturated fatty acids (LCPUFA) ≥ 20 carbons long are required for leukocyte function. These can be obtained from the diet, but there is some evidence that leukocytes can convert essential fatty acids (EFA) into LCPUFA. We used stable isotope tracers to investigate LCPUFA biosynthesis, and the effect of different EFA substrate ratios, in human T lymphocytes. CD3+ T cells were incubated for up to 48 hours with or without concanavalin A in media containing a 18:2n-6 : 18:3n-3 (EFA) ratio of either 5:1 or 8:1, and [13C]18:3n-3 plus [d5]18:2n-6. Mitogen stimulation increased the amounts of 16:1n 7, 18:1n 9, 18:2n 6, 20:3n 6, 20:4n 6, 18:3n 3 and 20:5n 3 in T cells. Expression of the activation marker CD69 preceded increased FADS2 and FADS1 mRNA expression, and increased amounts of [d5]20:2n 6 and [13C]20:3n 3 at 48 hours. 22 carbon n 6 or n 3 LCPUFA synthesis was not detected, consistent with the absence of ELOVL2 expression. An EFA ratio of 8:1 reduced 18:3n 3 conversion and enhanced 20:2n 6 synthesis compared to a 5:1 ratio. [d5]9- and [d5]-13-hydroxyoctadecadienoic (HODE) and [13C]9- and [13C]13-hydroxyoctadecatrienoic acids (HOTrE) were the major labelled oxylipins in culture supernatants; labelled oxylipins ≥ 20 carbons were not detected. An EFA ratio of 8:1 suppressed 9- and 13-HOTrE synthesis, but there was no significant effect on 9- and 13-HODE synthesis. These findings suggest that partitioning of newly assimilated EFA between LCPUFA synthesis and hydroxyoctadecaenoic acid may be a metabolic branch point in T cell EFA metabolism that has implications for understanding the effects of dietary fats on T lymphocyte function.

      RD Smith, CNM Kelly, BA Fielding, D Hauton, KDRR Silva, MC Nydahl, G Miller, CM Williams (2003)Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjects, In: BRITISH JOURNAL OF NUTRITION90(3)pp. 597-606 C A B I PUBLISHING
      C Beysen, F Karpe, BA Fielding, A Clark, JC Levy, KN Frayn (2002)Interaction between specific fatty acids, GLP-1 and insulin secretion in humans, In: DIABETOLOGIA45(11)pp. 1533-1541 SPRINGER-VERLAG
      SP Markkula, D Lyons, C-Y Yueh, C Riches, P Hurst, Barbara Fielding, LK Heisler, ML Evans (2016)Intracerebroventricular Catalase Reduces Hepatic Insulin Sensitivity and Increases Responses to Hypoglycemia in Rats, In: Endocrinology157(12)pp. 4669-4676 Endocrine Society

      Specialized metabolic-sensors in the hypothalamus regulate blood glucose levels by influencing hepatic glucose output and hypoglycemic counter regulatory responses. Hypothalamic reactive oxygen species (ROS) may act as a metabolic signal mediating responses to changes in glucose, other substrates and hormones. The role of ROS in the brain’s control of glucose homeostasis remains unclear. We hypothesized that hydrogen peroxide (H2O2), a relatively stable form of ROS, acts as a sensor of neuronal glucose consumption and availability and that lowering brain H2O2 with the enzyme catalase would lead to systemic responses increasing blood glucose. During hyperinsulinemic euglycemic clamps in rats, ICV catalase infusion resulted in increased hepatic glucose output, which was associated with reduced neuronal activity in the arcuate nucleus of the hypothalamus (ARC). Electrophysiological recordings revealed a subset of ARC neurons expressing pro-opiomelanocortin (POMC) that were inhibited by catalase and excited by H2O2. During hypoglycemic clamps, ICV catalase increased glucagon and epinephrine responses to hypoglycemia, consistent with perceived lower glucose levels. Our data suggest that H2O2 represents an important metabolic cue which, through tuning the electrical activity of key neuronal populations such as POMC neurons, may have a role in the brain’s influence of glucose homeostasis and energy balance.

      BA Fielding (2011)Tracing the fate of dietary fatty acids: metabolic studies of postprandial lipaemia in humans, In: Proceedings of the Nutrition Society70(3)pp. 342-350 Cambridge University Press

      Most postprandial studies have investigated the response of a single meal, yet the ingestion of sequential meals is more typical in a Western society. The aim of this review is to explain how natural and stable isotope tracers of fatty acids have been used to investigate the metabolism of dietary fat after single and multiple meals, with a focus on in vivo measurements of adipose tissue metabolism. When stable isotope tracers are combined with arteriovenous difference measurements, very specific measurements of metabolic flux across tissues can be made. We have found that adipose tissue is a net importer of dietary fat for 5 h following a single test meal and for most of the day during a typical three-meal eating pattern. When dietary fat is cleared from plasma, some fatty acids ‘spillover’ into the plasma and contribute up to 50 % of postprandial plasma non-esterified fatty acid concentrations. Therefore, plasma non-esterified fatty acid concentrations after a meal reflect the balance between intracellular and extracellular lipolysis in adipose tissue. This balance is altered after the acute ingestion of fructose. The enzyme lipoprotein lipase is a key modulator of fatty acid flux in adipose tissue and its rate of action is severely diminished in obese men. In conclusion, in vivo studies of human metabolism can quantify the way that fatty acid trafficking modulates plasma lipid concentrations. The magnitude of fatty acid flux from adipose tissue has implications for ectopic fat deposition in tissues such as the liver and muscle.

      A Bickerton, R Roberts, B Fielding, E Blaak, AJM Wagenmakers, M Gilbert, F Karpe, KN Frayn (2004)Fatty acid oxidation in the metabolic syndrome, In: ATHEROSCLEROSIS175(2)pp. S7-S7
      F Karpe, BA Fielding, V Ilic, IA Macdonald, LKM Summers, KN Frayn (2002)Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity, In: DIABETES51(8)pp. 2467-2473 AMER DIABETES ASSOC
      Jamie N. Pugh, Anton J.M Wagenmakers, Dominic A. Doran, Simon C. Fleming, Barbara Fielding, James P. Morton, Graeme L. Close (2020)Probiotic supplementation increases carbohydrate metabolism in trained male cyclists: a randomized, double-blind, placebo-controlled cross-over trial, In: AJP - Endocrinology and Metabolism American Physiological Society

      We hypothesised that probiotic supplementation (PRO) increases the absorption and oxidation of orally ingested maltodextrin during 2h endurance cycling, thereby sparing muscle glycogen for a subsequent time trial (simulating a road race). Measurements were made of lipid and carbohydrate oxidation, plasma metabolites and insulin, gastrointestinal permeability, and subjective symptoms of discomfort. Seven male cyclists were randomized to PRO (bacterial composition given in methods) or placebo (PLC) for four weeks, separated by a 14-day washout period. After each period, cyclists consumed a 10% maltodextrin solution (initial 8 mL·kg-1 bolus and 2 mL·kg-1 every 15 min) while exercising for 2h at 55% Wmax followed by a 100 kJ time trial. PRO resulted in small increases in peak oxidation rates of the ingested maltodextrin (0.84 ± 0.10 vs 0.77 ± 0.09 g·min-1, P = 0.016), and mean total carbohydrate oxidation (2.20 ± 0.25 vs 1.87 ± 0.39 g·min-1, P = 0.038), while fat oxidation was reduced (0.40 ± 0.11 vs 0.55 ± 0.10 g·min-1, P = 0.021) . During PRO small but significant increases were seen in glucose absorption, plasma glucose and insulin concentration and decreases in NEFA and glycerol. Differences between markers of GI damage and permeability and time trial performance were not significant (P > 0.05). In contrast to the hypothesis, PRO led to minimal increases in absorption and oxidation of the ingested maltodextrin and small reductions in fat oxidation, while having no effect on subsequent time trial performance.

      JL Ardilouze, BA Fielding, JM Curry, KN Frayn, F Karpe (2004)Role of leptin in regulating nitric oxide production and membrane microviscosity - Response, In: CIRCULATION109(22)pp. E316-E316 LIPPINCOTT WILLIAMS & WILKINS
      KN Frayn, JL Ardilouze, BA Fielding, F Karpe (2004)Coupling of metabolism and cardiovascular responses, In: CLINICAL SCIENCE106(5)pp. 547-548 PORTLAND PRESS
      Barbara Fielding (2017)Omega-3 index as a prognosis tool in cardiovascular disease, In: Current Opinion in Clinical Nutrition and Metabolic Care Wolters Kluwer Health, Inc.

      Purpose of review In 2004, the ‘omega-3 index’ was described as the sum of eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3) in red blood cells (RBCs) as an index of coronary heart disease mortality. This review outlines new evidence to support the omega-3 index as a tool to inform disease prognosis. Recent findings Recent studies have reported differential metabolism of EPA and DHA. High dose supplementation with EPA and DHA led to increased levels of RBC DHA that were associated with decreased liver fat. EPA and DHA in RBCs were associated with reduced mortality in a prospective study of patients with cardiac disease; the strongest association was with EPA. A diet containing 9.5 g alpha linolenic acid lead to an increase in EPA but not DHA status in middle aged women. Summary: Dietary intake or supplementation studies with n-3 fatty acids should include measurement of n-3 status in a standardised way. The omega-3 index, reflecting EPA and DHA status throughout the body, is convenient and may be appropriate in some cases, but since EPA and DHA assimilate differently in membranes, and have different potency, measurement of individual fatty acid composition in RBCs may be more informative

      F Karpe, BA Fielding, V Ilic, SM Humphreys, KN Frayn (2002)Monitoring adipose tissue blood flow in man: a comparison between the (133)xenon washout method and microdialysis, In: INTERNATIONAL JOURNAL OF OBESITY26(1)pp. 1-5 NATURE PUBLISHING GROUP
      LKM Summers, BA Fielding, V Ilic, ML Clark, KN Frayn (1999)The relationship between insulin sensitivity and postprandial adipose tissue lipid metabolism, In: DIABETOLOGIA42pp. A205-A205 SPRINGER VERLAG
      BA Griffin, BA Fielding (2001)Postprandial lipid handling, In: CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE4(2)pp. 93-98 LIPPINCOTT WILLIAMS & WILKINS
      F Karpe, BA Fielding, JL Ardilouze, V Ilic, IA Macdonald, KN Frayn (2002)Effects of insulin on adipose tissue blood flow in man, In: JOURNAL OF PHYSIOLOGY-LONDON540(3)pp. 1087-1093 CAMBRIDGE UNIV PRESS
      LKM Summers, BA Fielding, HA Bradshaw, V Ilic, C Beysen, ML Clark, NR Moore, KN Frayn (2002)Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity, In: DIABETOLOGIA45(3)pp. 369-377 SPRINGER-VERLAG
      C Beysen, AK Belcher, F Karpe, BA Fielding, E Herrera, KN Frayn (2003)Novel experimental protocol to increase specific plasma nonesterified fatty acids in humans, In: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM284(1)pp. E18-E24 AMER PHYSIOLOGICAL SOC
      MD Robertson, KG Jackson, CM Williams, BA Fielding, KN Frayn (2000)Modified sham feeding of a modest-fat meal suppresses plasma non-esterified fatty acids., In: PROCEEDINGS OF THE NUTRITION SOCIETY59pp. 123A-123A C A B INTERNATIONAL
      LKM Summers, BA Fielding, V Ilic, KN Frayn (1998)The relationship between body mass index, abdominal fat distribution, insulin sensitivity and plasma lipids, In: DIABETOLOGIA41pp. A347-A347 SPRINGER VERLAG
      L Hodson, BA Fielding (2012)Stearoyl-CoA desaturase: rogue or innocent bystander?, In: Prog Lipid Res52(1)pp. 15-42

      Different lipid fractions in humans have characteristic fatty acid profiles and these are maintained partly through diet and to a lesser extent through endogenous synthesis. The enzyme stearoyl-CoA desaturase (SCD; EC 1.14.99.5) is the rate-limiting enzyme in the synthesis of monounsaturated fatty acids such as palmitoleic acid (16:1 n-7) and oleic acid (18:1 n-9). These are the two most abundant monounsaturated fatty acids in human plasma lipids, membranes and adipose tissue. Although in quantitative terms, the endogenous synthesis of fatty acids in humans is not great in most circumstances, it is becoming increasingly evident that SCD plays important structural and metabolic roles. In addition, 16:1 n-7 has been purported to act as a beneficial 'lipokine' in an animal model. Research in humans has relied on indirect measurements of SCD1 activity and therefore, much of our understanding has come from work on animal models. However, results have been somewhat counterintuitive and confusing, so the purpose of this review is to try to summarise our current understanding of this fascinating enzyme.

      AD Sniderman, K Cianflone, L Summers, B Fielding, K Frayn (1997)The acylation-stimulating protein pathway and regulation of postprandial metabolism, In: PROCEEDINGS OF THE NUTRITION SOCIETY56(2)pp. 703-712
      KN Frayn, BA Fielding, JS Samra, LKM Summers (1997)Extracellular metabolic regulation in adipose tissue, In: PHYSIOLOGY, STRESS, AND MALNUTRITIONpp. 303-323
      J Saleh, LKM Summers, K Cianflone, BA Fielding, AD Sniderman, KN Frayn (1998)Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period, In: JOURNAL OF LIPID RESEARCH39(4)pp. 884-891 LIPID RESEARCH INC
      KG Jackson, MD Robertson, LO Deane, BA Fielding, KN Frayn, CM Williams (2000)The effect of modified sham-feeding meals of varying fat content on postprandial triacylglycerol, insulin and glucose responses., In: PROCEEDINGS OF THE NUTRITION SOCIETY59pp. 14A-14A C A B INTERNATIONAL
      KE Pinnick, MJ Neville, BA Fielding, KN Frayn, F Karpe, L Hodson (2012)Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans., In: Diabetes61(6)pp. 1399-1403 American Diabetes Association

      The expansion of lower-body adipose tissue (AT) is paradoxically associated with reduced cardiovascular disease and diabetes risk. We examined whether the beneficial metabolic properties of lower-body AT are related to the production and release of the insulin-sensitizing lipokine palmitoleate (16:1n-7). Using venoarterial difference sampling, we investigated the relative release of 16:1n-7 from lower-body (gluteofemoral) and upper-body (abdominal subcutaneous) AT depots. Paired gluteofemoral and abdominal subcutaneous AT samples were analyzed for triglyceride fatty acid composition and mRNA expression. Finally, the triglyceride fatty acid composition of isolated human preadipocytes was determined. Relative release of 16:1n-7 was markedly higher from gluteofemoral AT compared with abdominal subcutaneous AT. Stearoyl-CoA desaturase 1 (SCD1), the key enzyme involved in endogenous 16:1n-7 production, was more highly expressed in gluteofemoral AT and was associated with greater enrichment of 16:1n-7. Furthermore, isolated human preadipocytes from gluteofemoral AT displayed a higher content of SCD1-derived fatty acids. We demonstrate that human gluteofemoral AT plays a major role in determining systemic concentrations of the lipokine palmitoleate. Moreover, this appears to be an inherent feature of gluteofemoral AT. We propose that the beneficial metabolic properties of lower-body AT may be partly explained by the intrinsically greater production and release of palmitoleate.

      Simon Steenson, Margot Umpleby, JA Lovegrove, KG Jackson, Barbara Fielding (2017)Role of the enterocyte in fructose-induced hypertriglyceridaemia, In: Nutrients9(4)349 MDPI AG

      Abstract: Dietary fructose has been linked to an increased post-prandial triglyceride (TG) level, which is an established independent risk factor for cardiovascular disease. Although much research has focused on the effects of fructose consumption on liver-derived very-low density lipoprotein (VLDL), emerging evidence also suggests that fructose may raise post-prandial TG levels by affecting the metabolism of enterocytes of the small intestine. Enterocytes have become well recognised for their ability to transiently store lipids following a meal and to thus control post-prandial TG levels according to the rate of chylomicron (CM) lipoprotein synthesis and secretion. The influence of fructose consumption on several aspects of enterocyte lipid metabolism are discussed, including de novo lipogenesis, apolipoprotein B48 and CM-TG production, based on the findings of animal and human isotopic tracer studies. Methodological issues affecting the interpretation of fructose studies conducted to date are highlighted, including the accurate separation of CM and VLDL. Although the available evidence to date is limited, disruption of enterocyte lipid metabolism may make a meaningful contribution to the hypertriglyceridaemia often associated with fructose consumption.

      K Marinou, M Adiels, L Hodson, KN Frayn, F Karpe, BA Fielding (2011)Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men, In: BRITISH JOURNAL OF NUTRITION105(6)pp. 857-865 CAMBRIDGE UNIV PRESS
      Tracey M. Robertson, Abdulrahman Z. Alzaabi, M. Denise Robertson, Barbara A Fielding (2018)Starchy Carbohydrates in a Healthy Diet: The Role of the Humble Potato, In: Nutrients10(11) MDPI

      Potatoes have been an affordable, staple part of the diet for many hundreds of years. Recently however, there has been a decline in consumption, perhaps influenced by erroneous reports of being an unhealthy food. This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non-communicable diseases. Potatoes are an important source of micronutrients, such as vitamin C, vitamin B6, potassium, folate, and iron and contribute a significant amount of fibre to the diet. However, nutrient content is affected by cooking method; boiling causes leaching of water-soluble nutrients, whereas frying can increase the resistant starch content of the cooked potato. Epidemiological studies have reported associations between potato intake and obesity, type 2 diabetes and cardiovascular disease. However, results are contradictory and confounded by lack of detail on cooking methods. Indeed, potatoes have been reported to be more satiating than other starchy carbohydrates, such as pasta and rice, which may aid weight maintenance. Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food.

      L Hodson, K Harnden, R Banerjee, B Real, K Marinou, F Karpe, BA Fielding (2014)Lower resting and total energy expenditure in postmenopausal compared with premenopausal women matched for abdominal obesity., In: J Nutr Sci3pp. e3-?

      The menopause is accompanied by increased risk of obesity, altered body fat distribution and decreased skeletal muscle mass. The resulting decrease in RMR should be accompanied by a compensatory change in energy balance to avoid weight gain. We aimed to investigate habitual energy intake and expenditure in pre- and postmenopausal women matched for abdominal obesity. We recruited fifty-one healthy Caucasian women, BMI > 18·5 and 

      Margot Umpleby, F Shojaee-Moradie, Barbara Fielding, X Li, A Marino, N Alsini, Cheryl Isherwood, N Jackson, A Ahmad, M Stolinski, JA Lovegrove, Sigurd Johnsen, Agampodi Mendis, John Wright, ME Wilinska, R Hovorka, JD Bell, EL Thomas, GS Frost, Bruce Griffin (2017)Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets, In: Clinical Science131(21)pp. 2561-2573 Portland Press

      Dietary sugars are linked to the development of non-alcoholic fatty liver disease (NAFLD) and dyslipidaemia, but it is unknown if NAFLD itself influences the effects of sugars on plasma lipoproteins. To study this further, men with NAFLD (n=11) and low liver fat ‘controls’ (n= 14) were fed two iso-energetic diets, high or low in sugars (26% or 6% total energy) for 12 weeks, in a randomised, cross-over design. Fasting plasma lipid and lipoprotein kinetics were measured after each diet by stable isotope trace-labelling. There were significant differences in the production and catabolic rates of VLDL subclasses between men with NAFLD and controls, in response to the high and low sugar diets. Men with NAFLD had higher plasma concentrations of VLDL1-triacylglycerol (TAG) after the high (P

      R Roberts, AS Bickerton, BA Fielding, EE Blaak, AJ Wagenmakers, MF-F Chong, M Gilbert, F Karpe, KN Frayn (2008)Reduced oxidation of dietary fat after a short term high-carbohydrate diet, In: AMERICAN JOURNAL OF CLINICAL NUTRITION87(4)pp. 824-831 AMER SOC CLINICAL NUTRITION
      MF-F Chong, L Hodson, AS Bickerton, R Roberts, M Neville, F Karpe, KN Frayn, BA Fielding (2008)Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding, In: AMERICAN JOURNAL OF CLINICAL NUTRITION87(4)pp. 817-823 AMER SOC CLINICAL NUTRITION
      AST Bickerton, R Roberts, BA Fielding, H Tornqvist, EE Blaak, AJM Wagenmakers, M Gilbert, SM Humphreys, F Karpe, KN Frayn (2008)Adipose tissue fatty acid metabolism in insulin-resistant men, In: DIABETOLOGIA51(8)pp. 1466-1474 SPRINGER
      L Egli, F Theytaz, V Campos, L Hodson, P Schneiter, B Fielding, L Tappy (2012)Exercise Prevents Fructose-Induced Hypertriglyceridemia in Healthy Young Males, In: FASEB JOURNAL26
      Charlene Sibbons, N Irvine, J Pérez-Mojica, P Calder, K Lillycrop, Barbara Fielding, G Burdge (2018)Polyunsaturated fatty acid biosynthesis involving 8 desaturation and differential DNA methylation of FADS2 regulates proliferation of human peripheral blood mononuclear cells, In: Frontiers in Immunology9 Frontiers Media

      Polyunsaturated fatty acids (PUFAs) are important for immune function. Limited evidence indicates that immune cell activation involves endogenous PUFA synthesis, but this has not been characterised. To address this, we measured metabolism of 18:3n-3 in quiescent and activated peripheral blood mononuclear cells (PBMCs), and in Jurkat T cell leukaemia. PBMCs from men and women (n = 34) were incubated with [1-13C]18:3n-3 with or without Concanavalin A (Con. A). 18:3n-3 conversion was undetectable in unstimulated PBMCs, but up-regulated when stimulated. The main products were 20:3n-3 and 20:4n-3, while 18:4n-3 was undetectable, suggesting initial elongation and 8 desaturation. PUFA synthesis was 17.4-fold greater in Jurkat cells than PBMCs. The major products of 18:3n-3 conversion in Jurkat cells were 20:4n-3, 20:5n-3 and 22:5n-3. 13C Enrichment of 18:4n-3 and 20:3n-3 suggests parallel initial elongation and Δ6 desaturation. The FADS2 inhibitor SC26196 reduced PBMC, but not Jurkat cell, proliferation suggesting PUFA synthesis is involved in regulating mitosis in PBMCs. Con. A stimulation increased FADS2, FADS1, ELOVL5 and ELOVL4 mRNA expression in PBMCs. A single transcript corresponding to the major isoform of FADS2, FADS20001, was detected in PBMCs and Jurkat cells. PBMC activation induced hypermethylation of a 470bp region in the FADS2 5’-regulatory sequence. This region was hypomethylated in Jurkat cells compared to quiescent PBMCs. These findings show that PUFA synthesis involving initial elongation and 8 desaturation is involved in regulating PBMC proliferation and is regulated via transcription possibly by altered DNA methylation. These processes were dysregulated in Jurkat cells. This has implications for understanding the regulation of mitosis in normal and transformed lymphocytes.

      KE Pinnick, SC Collins, C Londos, D Gauguier, A Clark, BA Fielding (2008)Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition, In: OBESITY16(3)pp. 522-530 NATURE PUBLISHING GROUP
      BA Fielding, SM Humphreys, KN Frayn (1993)Mono- and di-acylglycerol concentrations in human plasma in relation to lipoprotein lipase activity., In: Biochem Soc Trans21 ( P(3)pp. 235S-?
      MF-F Chong, BA Fielding, KN Frayn (2007)Mechanisms for the acute effect of fructose on postprandial lipemia, In: AMERICAN JOURNAL OF CLINICAL NUTRITION85(6)pp. 1511-1520 AMER SOC CLINICAL NUTRITION
      U Riserus, D Sprecher, T Johnson, E Olson, S Hirschberg, A Liu, Z Fang, P Hegde, D Richards, L Sarov-Blat, JC Strum, S Basu, J Cheeseman, BA Fielding, SM Humphreys, T Danoff, NR Moore, P Murgatroyd, S O'Rahilly, P Sutton, T Willson, D Hassall, KN Frayn, F Karpe (2008)Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatly acid oxidation in moderately obese men, In: DIABETES57(2)pp. 332-339 AMER DIABETES ASSOC
      L Hodson, AST Bickerton, SE McQuaid, R Roberts, F Karpe, KN Frayn, BA Fielding (2007)The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women - Studies in the postprandial state, In: DIABETES56(10)pp. 2433-2441 AMER DIABETES ASSOC
      L Hodson, CM Skeaff, BA Fielding (2008)Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake, In: PROGRESS IN LIPID RESEARCH47(5)pp. 348-380 PERGAMON-ELSEVIER SCIENCE LTD
      L Hodson, K Harnden, R Banerjee, B Rial, K Marinou, F Karpe, BA Fielding (2014)Lower resting and total energy expenditure in post-menopausal compared with pre-menopausal women matched for abdominal obesity, In: The British Journal of Nutrition: an international journal of nutritional science3pp. 1-9 Cambridge University Press

      The menopause is accompanied by increased risk of obesity, altered body fat distribution, and decreased skeletal muscle mass. The resulting decrease in RMR should be accompanied by a compensatory change in energy balance to avoid weight gain. We aimed to investigate habitual energy intake and expenditure in pre- and post-menopausal women matched for abdominal obesity. We recruited fifty-one healthy Caucasian women, BMI >18.5 and < 35, aged 35 - 45 years (pre-menopausal, n=26) and 55-65 years (post-menopausal, n=25). Energy intake was measured using 3-day diet diaries and dietary fat quality assessed using adipose tissue fatty acid biomarkers. RMR was measured using indirect calorimetry, and total (TEE) and activity energy expenditure using a combined accelerometer and heart rate monitor. Post-menopausal women had lower RMR and TEE and spent significantly less time undertaking moderate exercise than pre-menopausal women. Post-menopausal women had a tendency for a lower calorie intake, and a similar macronutrient intake but a significantly lower adipose tissue n-6/n-3 index (24.6 (1.6) v 37.7 (3.1), P

      F Karpe, AS Bickerton, L Hodson, BA Fielding, GD Tan, KN Frayn (2007)Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation, In: BIOCHEMICAL SOCIETY TRANSACTIONS35pp. 472-476 PORTLAND PRESS LTD
      Barbara A Fielding, Philip C Calder, Nicola A Irvine, Elizabeth A Miles, Karen A Lillycrop, Johanna von Gerichten, Graham C Burdge (2019)How does polyunsaturated fatty acid biosynthesis regulate T lymphocyte function?, In: Nutrition Bulletin44(4)pp. 350-355 Wiley

      mpaired regulation of immune function characterised by chronic inflammation together with a declining protective immune response is a major challenge to healthy ageing. It is therefore important to understand the mechanisms that regulate immune function and the impact of ageing upon such processes. Appropriate induction and resolution of the immune response requires adequate availability of polyunsaturated fatty acids (PUFAs) for incorporation into cell membranes. However, humans are unable to synthesise PUFAs de novo and are dependent upon dietary intake for pre-formed PUFAs or synthesis by the liver from the essential fatty acids, linoleic acid (LA, 18:2n-6) and alpha-linolenic acid (aLNA, 18:3n-3). We have shown that activation of peripheral blood mononuclear cells (PBMCs) 37 increases PUFA biosynthesis from essential fatty acids via a mechanism that involves altered epigenetic regulation of a key gene in the pathway. Moreover, induction of PUFA synthesis is directly involved in the regulation of lymphocyte activation and proliferation. The aim of the BBSRC responsive mode award ‘How does polyunsaturated fatty acid biosynthesis regulate T lymphocyte function?’ is to determine how PUFA biosynthesis regulates T cell function and the effect of ageing on this process. The project will identify points of regulation in the biosynthetic pathway and how these might influence the capacity for up-regulation of PUFA synthesis in older individuals. We will use stable isotope tracers of LA and aLNA to determine whether newly synthesised PUFAs are preferential substrates for synthesis of lipid mediators and whether they are involved in formation of membrane microdomains that mediate cell signalling.

      EM Ooi, DC Chan, L Hodson, M Adiels, J Boren, F Karpe, BA Fielding, GF Watts, PHR Barrett (2016)Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III, In: European Journal of Clinical Investigation46(8)pp. 730-736

      Background Experimental data suggest that apolipoprotein (apo) C-II and C-III regulate triglyceride-rich lipoprotein (TRL) metabolism, but there are limited studies in humans. We investigated the metabolic associations of TRLs with apoC-II and apoC-III concentrations and kinetics in women. Material and methods The kinetics of plasma apoC-II, apoC-III and very low-density lipoprotein (VLDL) apoB-100 and triglycerides were measured in the postabsorptive state using stable isotopic techniques and compartmental modeling in 60 women with wide-ranging body mass index (19.5-32.9kg/m2). Results Plasma apoC-II and apoC-III concentrations were positively associated with the concentration of plasma triglycerides, VLDL1- and VLDL2- apoB-100 and triglyceride (all P

      C Tran, D Jacot-Descombes, V Lecoultre, BA Fielding, G Carrel, K-A Le, P Schneiter, M Bortolotti, KN Frayn, L Tappy (2010)Sex differences in lipid and glucose kinetics after ingestion of an acute oral fructose load, In: BRITISH JOURNAL OF NUTRITION104(8)pp. 1139-1147 CAMBRIDGE UNIV PRESS
      Jennifer Moore, Annabelle Horti, Barbara Fielding (2018)Evaluation of the nutrient content of yogurts: a comprehensive survey of yogurt products in the major UK supermarkets, In: BMJ Open8(8)e021387 BMJ Publishing Group:

      Objectives: To comprehensively survey the sugar and nutrient contents of yogurt products available in UK supermarkets, in particular those marketed to children. Design: A cross-sectional survey of yogurt products available in the UK’s supermarkets in November 2016. Methods: Data were collected from five major online UK supermarkets and a process flow strategy was used to place yogurts into eight categories: children’s, dairy alternatives, dessert, drinks, fruit, flavoured, natural/Greek style and organic. A comprehensive database of product information for 921 unique products was created and analysed. Results: The total sugar, fat, protein, calcium and energy contents were highly variable across categories, and the ranges were extremely broad. Although lower than the dessert category, the medians (range) of the total sugar content of children’s (10.8 g/100 g (4.8–14.5)), fruit (11.9 g/100 g (4.6–21.3)), flavoured (12.0 g/100 g (0.1–18.8)) and organic (13.1 g/100 g (3.8–16.9)) yogurt products were all well above 10 g/100 g, and represented >45% of total energy. Only two out of 101 children’s yogurt and fromage frais products surveyed qualified as low sugar (≤5 g/100 g). Natural/Greek yogurts had dramatically lower sugar contents (5.0 g/100 g (1.6, 9.5), largely lactose) than all other categories. While low-fat (

      Pauline Morigny, Marianne Houssier, Aline Mairal, Claire Ghilain, Mouisel Etienne, Fadila Benhamed, Bernard Masri, Emeline Recazens, Pierre-Damien Denechaud, Geneviève Tavernier, Sylvie Caspar-Bauguil, Sam Virtue, Veronika Sramkova, Laurent Monbrun, Anne Mazars, Madjid Zazoun, Sandra Guilmeau, Valentin Barquissau, Diane Beuzelin, Sophie Bonnel, Marie Marques, Boris Monge-Roffarello, Corinne Lefort, Barbara Fielding, Thierry Sulpice, Arne Astrup, Bernard Payrastre, Justine Bertrand-Michel, Emmanuelle Meugnier, Laetitia Ligat, Frederic Lopez, Hervé Guillou, Charlotte Ling, Cecilia Holm, Remi Rabasa-Lhoret, Wim Saris, Vladimir Stich, Peter Arner, Mikael Ryden, Cedric Moro, Nathalie Viguerie, Matthew Harms, Stefan Hallén, Antonio Vidal-Puig, Hubert Vidal, Catherine Postic, Dominique Langin (2018)Interaction between Hormone-Sensitive Lipase and ChREBP in Fat Cells Controls Insulin Sensitivity, In: Nature Metabolism Nature Research

      Impaired adipose tissue insulin signalling is a critical feature of insulin resistance. Here we identify a pathway linking the lipolytic enzyme hormone-sensitive lipase (HSL) to insulin action via the glucose-responsive transcription factor ChREBP and its target, the fatty acid elongase ELOVL6. Genetic inhibition of HSL in human adipocytes and mouse adipose tissue results in enhanced insulin sensitivity and induction of ELOVL6. ELOVL6 promotes an increase in phospholipid oleic acid, which modifies plasma membrane fluidity and enhances insulin signalling. HSL deficiency–mediated effects are suppressed by gene silencing of ChREBP and ELOVL6. Mechanistically, physical interaction between HSL, independent of lipase activity, and the isoform activated by glucose metabolism ChREBPα impairs ChREBPα translocation into the nucleus and induction of ChREBPβ, the isoform with high transcriptional activity that is strongly associated with whole-body insulin sensitivity. Targeting the HSL–ChREBP interaction may allow therapeutic strategies for the restoration of insulin sensitivity.

      SR Lord, J Collins, B Fielding, F Buffa, F Karpe, A Harris (2011)METFORMIN'S EFFECTS ON BREAST CANCER LIPID METABOLISM, In: ANNALS OF ONCOLOGY22pp. 31-31
      KN Frayn, S Shadid, R Hamlani, SM Humphreys, ML Clark, BA Fielding, O Boland, SW Coppack (1994)Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition, In: American Journal of Physiology - Endocrinology and Metabolism266(3 29-3)

      There is net outward flow of fatty acids from adipose tissue in the fasted state but net inward flow and storage in the postprandial state. We investigated how this is regulated. Arteriovenous differences were measured across a subcutaneous adipose depot in six normal subjects before and for 5 h after a meal containing 80 g fat and 80 g carbohydrate. In five further experiments, insulin was infused at 40 mU · m -2 · min -1 from 30 min after the meal, clamping the plasma glucose. Net transcapillary fatty acid flow changed from negative (outward flow from tissue to capillaries) in the postabsorptive state to consistently positive (net inward flow, implying fat storage) after the meal despite continued net efflux of fatty acids into venous blood. In the 'clamped' experiments (with additional insulin), net fatty acid efflux in the venous blood was suppressed and positive transcapillary flux (storage) was more marked. Regulation of fatty acid flow appeared to depend on coordinated changes in hormone-sensitive lipase (HSL) and lipoprotein lipase (LPL) action and fatty acid esterification. Additional insulin caused no further suppression of HSL or activation of LPL but markedly stimulated fatty acid retention (presumed to represent esterification). In the absence of additional insulin, a high proportion of the fatty acids liberated by LPL are released into the venous plasma in both postabsorptive and postprandial states. We hypothesize that this 'loss' of fatty acids is necessary to give precise control to the pathway of fat storage.

      AG DAVIES, DA PRICE, CA HOULTON, JL BURN, BA FIELDING, RJ POSTLETHWAITE (1984)CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN DIABETES-MELLITUS - A YEARS PROSPECTIVE TRIAL, In: ARCHIVES OF DISEASE IN CHILDHOOD59(11)pp. 1027-1033 BRITISH MED JOURNAL PUBL GROUP
      BA FIELDING, SM HUMPHREYS, S SHADID, KN FRAYN (1995)PLASMA MONOACYLGLYCEROL, DIACYLGLYCEROL AND TRIACYLGLYCEROL MEASUREMENTS IN A STUDY OF FAT UPTAKE BY HUMAN ADIPOSE-TISSUE IN-VIVO, In: BIOCHEMICAL SOCIETY TRANSACTIONS23(3)pp. S487-S487
      EM Maldonado, BA Fielding, CP Fisher, JB Moore (2015)Quantitative lipid profiling of the early response to either fructose or glucose in an in vitro model of steatosis, In: PROCEEDINGS OF THE NUTRITION SOCIETY74(OCE5)pp. E282-E282
      CA Hartwick, L Moreno, M Fisberg, K Hart, B Fielding, S Lenham-New, Z Richards (2014)An international study of food behavior and nutritional status of children from 21 countries, In: FASEB JOURNAL28(1)
      L Hodson, SE McQuaid, F Karpe, KN Frayn, BA Fielding (2009)Differences in partitioning of meal fatty acids into blood lipid fractions: a comparison of linoleate, oleate, and palmitate, In: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM296(1)pp. E64-E71 AMER PHYSIOLOGICAL SOC
      F Bernini, P Costet, E Ehrenborg, R Fisher, B Fielding, D Freeman, A Groen, E Malle, M Mulder, A Niemeier, AT Hansen, A von Eckardstein (2012)European Lipoprotein Club: Report of the 34th ELC annual conference, Tutzing, 5-8 September 2011, In: Atherosclerosis221(1)pp. 287-293
      K Pinnick, M Neville, A Clark, B Fielding (2010)Reversibility of Metabolic and Morphological Changes Associated With Chronic Exposure of Pancreatic Islet beta-Cells to Fatty Acids, In: JOURNAL OF CELLULAR BIOCHEMISTRY109(4)pp. 683-692 WILEY-LISS
      L Hodson, BA Fielding (2010)Trafficking and partitioning of fatty acids: the transition from fasted to fed state, In: CLINICAL LIPIDOLOGY5(1)pp. 131-144 FUTURE MEDICINE LTD
      BA FIELDING, DA PRICE, CA HOULTON (1983)ENZYME-IMMUNOASSAY FOR URINARY ALBUMIN, In: CLINICAL CHEMISTRY29(2)pp. 355-357 AMER ASSOC CLINICAL CHEMISTRY
      BA Fielding, SM Humphreys, S Shadid, KN Frayn (1995)Plasma mono-, di- and triacylglycerol measurements in a study of fat uptake by human adipose tissue in vivo., In: Biochem Soc Trans23(3)pp. 487S-?
      SE McQuaid, L Hodson, MJ Neville, AL Dennis, J Cheeseman, SM Humphreys, T Ruge, M Gilbert, BA Fielding, KN Frayn, F Karpe (2011)Downregulation of Adipose Tissue Fatty Acid Trafficking in Obesity A Driver for Ectopic Fat Deposition?, In: DIABETES60(1)pp. 47-55 AMER DIABETES ASSOC
      AJ GRIFFITHS, SM HUMPHREYS, ML CLARK, BA FIELDING, KN FRAYN (1994)IMMEDIATE METABOLIC AVAILABILITY OF DIETARY-FAT IN COMBINATION WITH CARBOHYDRATE, In: AMERICAN JOURNAL OF CLINICAL NUTRITION59(1)pp. 53-59 AMER SOC CLINICAL NUTRITION
      J Lundbom, S Heikkinen, B Fielding, A Hakkarainen, M-R Taskinen, N Lundbom (2009)PRESS echo time behavior of triglyceride resonances at 1.5 T: Detecting omega-3 fatty acids in adipose tissue in vivo, In: JOURNAL OF MAGNETIC RESONANCE201(1)pp. 39-47 ACADEMIC PRESS INC ELSEVIER SCIENCE
      P Iozzo, M Bucci, A Roivainen, K Nagren, MJ Jaervisalo, J Kiss, L Guiducci, B Fielding, AG Naum, R Borra, K Virtanen, T Savunen, PA Salvadori, E Ferrannini, J Knuuti, P Nuutila (2010)Fatty Acid Metabolism in the Liver, Measured by Positron Emission Tomography, Is Increased in Obese Individuals, In: GASTROENTEROLOGY139(3)pp. 846-U203 W B SAUNDERS CO-ELSEVIER INC
      M Umpleby, F Shojaee-Moradie, B Fielding, X Li, C Isherwood, N Jackson, G Wilinska, R Hovorka, J Bell, EL Thomas, J Wright, GS Frost, B Griffin (2015)A DIET LOW IN SUGAR REDUCES THE PRODUCTION OF ATHEROGENIC LIPOPROTEINS IN MEN WITH HIGH LIVER FAT, In: ATHEROSCLEROSIS241(1)pp. E46-E46
      BA Fielding, SM Humphreys, S Shadid, KN Frayn (1995)Arterio-venous differences across human adipose tissue for mono-, di- and triacylglycerols before and after a high-fat meal, In: Endocrinology and Metabolism2(1)pp. 13-17

      The purpose of this study was to determine whether or not partial acylglycerols, resulting from triacylglycerol hydrolysis, accumulate during the process of fat deposition in vivo. We measured mono-, di- and triacylglycerol levels in arterialized and adipose tissue venous plasma in normal subjects before and after a test meal. The mean concentrations of partial acylglycerols were consistently low in all plasma samples, accounting for less than 2% of the total acylglycerol measurement. The absence of monoacylglycerol accumulation in the adipose tissue venous plasma samples indicates that the disposal of monoacylglycerol by the adipose tissue was not rate limiting for complete hydrolysis of triacylglycerol in vivo. After heparin was injected intravenously 300 min after the high-fat meal, the mean concentration of monoacylglycerol in arterialized plasma increased from 1.6 ± 0.6 μmol/l to 106 ± 19 μmol/l (P = 0.01), whereas the mean concentration of diacylglycerol did not change (13.0 ± 2.3 μmol/l before, 17.4 ± 4.2 μmol/l after).

      GD Tan, DB Savage, BA Fielding, J Collins, L Hodson, SM Humphreys, S O'Rahilly, K Chatterjee, KN Frayn, F Karpe (2008)Fatty Acid Metabolism in Patients with PPAR gamma Mutations, In: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM93(11)pp. 4462-4470 ENDOCRINE SOC
      MFF Chong, A Bickerton, R Roberts, F Karpe, L Hodson, B Fielding, K Frayn (2006)De novo lipogenesis (DNL) occurs after a 3-day eucaloric low-fat, high-carbohydrate (HC) solid food diet, In: FASEB JOURNAL20(5)pp. A1022-A1023
      A Karmi, P Iozzo, A Viljanen, J Hirvonen, BA Fielding, K Virtanen, V Oikonen, J Kemppainen, T Viljanen, L Guiducci, M Haaparanta-Solin, K Nagren, O Solin, P Nuutila (2010)Increased Brain Fatty Acid Uptake in Metabolic Syndrome, In: DIABETES59(9)pp. 2171-2177 AMER DIABETES ASSOC
      M Adiels, T Larsson, P Sutton, M-R Taskinen, J Boren, BA Fielding (2010)Optimization of N-methyl-N-[tert-butyldimethylsilyl]- trifluoroacetamide as a derivatization agent for determining isotopic enrichment of glycerol in very-low density lipoproteins, In: RAPID COMMUNICATIONS IN MASS SPECTROMETRY24(5)pp. 586-592 JOHN WILEY & SONS LTD
      F Karpe, BA Fielding, SW Coppack, VJ Lawrence, IA Macdonald, KN Frayn (2005)Oscillations of fatty acid and glycerol release from human subcutaneous adipose tissue in vivo, In: DIABETES54(5)pp. 1297-1303 AMER DIABETES ASSOC
      A Kotronen, J Westerbacka, BA Fielding, J Wahren, L Hodson, T Seppanen-Laakso, T Suortti, J Arola, R Hultcrantz, S Castillo, KN Frayn, M Oresic, H Yki-Jarvinen (2010)Splanchnic balance of free fatty acids, endocannabinoids and lipids in subjects with NAFLD, In: DIABETOLOGIA53pp. S104-S104
      AG DAVIES, DA PRICE, RJ POSTLETHWAITE, BA FIELDING (1985)URINE ALBUMIN EXCRETION IN DIABETICS, In: LANCET1(8426)pp. 466-467 LANCET LTD
      DA PRICE, GC CLOSE, BA FIELDING (1984)AGE OF APPEARANCE OF CIRCADIAN-RHYTHM IN SALIVARY CORTISOL-LEVELS, In: PEDIATRIC RESEARCH18(1)pp. 118-118 WILLIAMS & WILKINS
      BA FIELDING, CA HOULTON, DA PRICE, RJ POSTLETHWAITE (1983)AN ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR THE MEASUREMENT OF URINARY ALBUMIN, In: EUROPEAN JOURNAL OF PEDIATRICS140(2)pp. 207-207 SPRINGER VERLAG
      KN Frayn, BA Fielding, SM Humphreys, SW Coppack (1996)Nutritional influences on human adipose-tissue metabolism, In: BIOCHEMICAL SOCIETY TRANSACTIONS24(2)pp. 422-426 PORTLAND PRESS
      J Westerbacka, A Kotronen, BA Fielding, J Wahren, L Hodson, J Perttila, T Seppanen-Laakso, T Suortti, J Arola, R Hultcrantz, S Castillo, VM Olkkonen, KN Frayn, M Oresic, H Yki-Jarvinen (2010)Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects With Nonalcoholic Fatty Liver Disease, In: GASTROENTEROLOGY139(6)pp. 1961-U232 W B SAUNDERS CO-ELSEVIER INC
      AG DAVIES, DA PRICE, RJ POSTLETHWAITE, GM ADDISON, JL BURN, BA FIELDING (1985)RENAL-FUNCTION IN DIABETES-MELLITUS, In: ARCHIVES OF DISEASE IN CHILDHOOD60(4)pp. 299-304 BRITISH MED JOURNAL PUBL GROUP
      C Sibbons, L Boyle, GC Burdge, M Umpleby, KA Lilycrop, CA Hartwick, S Lanham-New, K Hart, BA Fielding (2015)Evaluation of fatty acid status in children of different nationalities, In: PROCEEDINGS OF THE NUTRITION SOCIETY74(OCE1)pp. E94-E94 CAMBRIDGE UNIV PRESS
      T Ruge, L Hodson, J Cheeseman, AL Dennis, BA Fielding, SM Humphreys, KN Frayn, F Karpe (2009)Fasted to Fed Trafficking of Fatty Acids in Human Adipose Tissue Reveals a Novel Regulatory Step for Enhanced Fat Storage, In: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM94(5)pp. 1781-1788 ENDOCRINE SOC
      SE McQuaid, SM Humphreys, L Hodson, BA Fielding, F Karpe, KN Frayn (2010)Femoral Adipose Tissue May Accumulate the Fat That Has Been Recycled as VLDL and Nonesterified Fatty Acids, In: DIABETES59(10)pp. 2465-2473 AMER DIABETES ASSOC
      J Lundbom, A Hakkarainen, B Fielding, S Soderlund, J Westerbacka, M-R Taskinen, N Lundbom (2010)Characterizing human adipose tissue lipids by long echo time H-1-MRS in vivo at 1.5 Tesla: validation by gas chromatography, In: NMR IN BIOMEDICINE23(5)pp. 466-472 WILEY-BLACKWELL
      KN Frayn, BA Fielding, LKM Summers (1997)Investigation of human adipose tissue metabolism in vivo, In: JOURNAL OF ENDOCRINOLOGY155(2)pp. 187-189 J ENDOCRINOLOGY LTD
      DA PRICE, GC CLOSE, BA FIELDING (1983)AGE OF APPEARANCE OF CIRCADIAN-RHYTHM IN SALIVARY CORTISOL VALUES IN INFANCY, In: ARCHIVES OF DISEASE IN CHILDHOOD58(6)pp. 454-456 BRITISH MED JOURNAL PUBL GROUP
      L Hodson, SE McQuaid, SM Humphreys, R Milne, BA Fielding, KN Frayn, F Karpe (2010)Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?, In: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM299(4)pp. E584-E592 AMER PHYSIOLOGICAL SOC
      BA FIELDING, SM HUMPHREYS, RFC ALLMAN, KN FRAYN (1993)MONOACYLGLYCEROL, DIACYLGLYCEROL, AND TRIACYLGLYCEROL CONCENTRATIONS IN HUMAN PLASMA - EFFECTS OF HEPARIN INJECTION AND OF A HIGH-FAT MEAL, In: CLINICA CHIMICA ACTA216(1-2)pp. 167-173 ELSEVIER SCIENCE BV
      H DHAR, BA FIELDING, ML CLARK, KN FRAYN (1990)TURBIDITY IN IMMUNOTURBIDIMETRIC ASSAY - REPLY, In: ANNALS OF CLINICAL BIOCHEMISTRY27pp. 509-509 ROYAL SOC MEDICINE SERVICES LTD
      KN Frayn, LKM Summers, BA Fielding (1997)Regulation of the plasma non-esterified fatty acid concentration in the postprandial state, In: PROCEEDINGS OF THE NUTRITION SOCIETY56(2)pp. 713-721 C A B INTERNATIONAL
      AD Robertson, KG Jackson, BA Fielding, CM Williams, KN Frayn (2002)Acute effects of meal fatty acid composition on insulin sensitivity in healthy post-menopausal women, In: BRITISH JOURNAL OF NUTRITION88(6)pp. 635-640 C A B I PUBLISHING
      U Harjes, E Bridges, KM Gharpure, I Roxanis, H Sheldon, F Miranda, LS Mangala, S Pradeep, G Lopez-Berestein, BA Fielding, A Ahmed, AK Sood, A Harris (2017)Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4, In: Oncogene36(7)pp. 912-921 Nature Publishing Group

      Fatty acid binding protein 4 (FABP4) is a fatty acid chaperone, which is induced during adipocyte differentiation. Previously we have shown that endothelial FABP4 is induced by the NOTCH1 signalling pathway, which is involved in mechanisms of resistance to anti-angiogenic tumour therapy1. Here, we investigated the role of FABP4 in endothelial fatty acid metabolism and tumour angiogenesis. We analysed the effect of transient FABP4 knockdown in human umbilical vein endothelial cells on fatty acid metabolism, viability, and angiogenesis. Through therapeutic delivery of siRNA targeting murine FABP4, we investigated the effect of stromal FABP4 knockdown on tumour growth and blood vessel formation. In vitro, siRNA-mediated FABP4 knockdown in endothelial cells led to a marked increase of endothelial fatty acid oxidation, an increase of reactive oxygen species (ROS), and decreased angiogenesis. In vivo, we found that increased NOTCH1 signalling in tumour xenografts led to increased expression of endothelial FABP4 that decreased when NOTCH1 and VEGFA inhibitors were used in combination. Angiogenesis, growth, and metastasis in ovarian tumour xenografts were markedly inhibited by therapeutic siRNA delivery targeting mouse FABP4. Therapeutic targeting of endothelial FABP4 by siRNA in vivo has anti-angiogenic and anti-tumour effects with minimal toxicity and should be investigated further.

      KJ Halliwell, BA Fielding, JS Samra, SM Humphreys, KN Frayn (1996)Release of individual fatty acids from human adipose tissue in vivo after an overnight fast, In: JOURNAL OF LIPID RESEARCH37(9)pp. 1842-1848 LIPID RESEARCH INC
      DIW Phillips, S Caddy, V Ilic, BA Fielding, KN Frayn, AC Borthwick, R Taylor (1996)Intramuscular triglyceride and muscle insulin sensitivity: Evidence for a relationship in nondiabetic subjects, In: METABOLISM-CLINICAL AND EXPERIMENTAL45(8)pp. 947-950 W B SAUNDERS CO
      GD Tan, BA Fielding, JM Currie, SM Humphreys, M Desage, K Frayn, M Laville, H Vidal, F Karpe (2005)The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes, In: DIABETOLOGIA48(1)pp. 83-95 SPRINGER
      U Riserus, GD Tan, BA Fielding, MJ Neville, J Currie, DB Savage, VK Chatterjee, KN Frayn, S O'Rahilly, F Karpe (2005)Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans - Link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma, In: DIABETES54(5)pp. 1379-1384 AMER DIABETES ASSOC
      KN Frayn, BA Fielding, F Karpe (2005)Adipose tissue fatty acid metabolism and cardiovascular disease, In: CURRENT OPINION IN LIPIDOLOGY16(4)pp. 409-415 LIPPINCOTT WILLIAMS & WILKINS
      JL Ardilouze, BA Fielding, JM Currie, KN Frayn, F Karpe (2004)Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans, In: CIRCULATION109(1)pp. 47-52 LIPPINCOTT WILLIAMS & WILKINS
      BA Fielding, J Callow, RM Owen, JS Samra, DR Matthews, KN Frayn (1996)Postprandial lipemia: The origin of an early peak studied by specific dietary fatty acid intake during sequential meals, In: AMERICAN JOURNAL OF CLINICAL NUTRITION63(1)pp. 36-41 AMER SOC CLIN NUTRITION INC
      JH Moffitt, BA Fielding, R Evershed, R Berstan, JM Currie, A Clark (2005)Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro, In: DIABETOLOGIA48(9)pp. 1819-1829 SPRINGER
      A Kotronen, A Seppala-Lindroos, S Vehkavaara, R Bergholm, KN Frayn, BA Fielding, H Yki-Javinen (2009)Liver fat and lipid oxidation in humans, In: LIVER INTERNATIONAL29(9)pp. 1439-1446 WILEY-BLACKWELL PUBLISHING, INC
      H Sell, M Blueher, N Kloeting, R Schlich, M Willems, F Ruppe, WT Knoefel, A Dietrich, BA Fielding, P Arner, KN Frayn, J Eckel (2013)Adipose Dipeptidyl Peptidase-4 and Obesity Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro, In: DIABETES CARE36(12)pp. 4083-4090 AMER DIABETES ASSOC
      MD Robertson, KG Jackson, BA Fielding, LM Morgan, CM Williams, KN Frayn (2002)Acute ingestion of a meal rich in n-3 polyunsaturated fatty acids results in rapid gastric emptying in humans, In: AMERICAN JOURNAL OF CLINICAL NUTRITION76(1)pp. 232-238 AMER SOC CLINICAL NUTRITION
      Charlotte Mills, Scott V Harding, Mariam Bapir, Giuseppina Mandalari, Louise J Salt, Robert Gray, BARBARA ANN FIELDING, Peter J Wilde, Wendy L Hall, Sarah E Berry (2020)Palmitic acid-rich oils with and without interesterification lower postprandial lipemia and increase atherogenic lipoproteins compared to a MUFA-rich oil: A randomized controlled trial, In: American Journal of Clinical Nutrition American Society for Nutrition

      Background: Interesterified (IE) fats are widely used in place of trans fats; however, little is known about their metabolism. Objective: To test the impact of a commonly consumed IE versus a non-IE equivalent fat on in vivo postprandial and in vitro lipid metabolism, compared with a reference oil (rapeseed oil; RO). Design: A double-blinded, 3-phase crossover, randomized controlled trial was performed in healthy adults (n=20) aged 45-75 years. Postprandial plasma triacylglycerol (TG) and lipoprotein responses (including stable isotope tracing) to a test meal (50g fat) were evaluated over 8 hours. The test fats were IE 80:20 palm stearin/palm kernel fat, an identical non-IE fat, and RO (control). In vitro, mechanisms of digestion were explored using a dynamic gastric model (DGM). Results: Plasma TG 8h incremental area under the curves were lower following non-IE versus RO (-1.7 mmol/L.h (95% confidence interval -3.3, -0.0)), but there were no differences between IE and RO nor IE and non-IE. Low density lipoprotein (LDL) particles were smaller following IE and non-IE versus RO (P=0.005). Extra, extra large (XXL)-, extra large (XL)- and large (L)- VLDL particle concentrations were higher following IE and non-IE versus RO at 6-8 h (P

      Barbara A Fielding, Bruce A Griffin, Wendy Hall, Leanne Hodson, Rona Antoni, A. Margot Umpleby, Tracey Robertson, Tom Preston, Matthew Brook, Katherine Pinnick (2020)Report of a member-led meeting: how stable isotope techniques can enhance human nutrition research, In: Proceedings of the Nutrition Society79(3)pp. 373-379 Cambridge University Press

      A Nutrition Society member-led meeting was held on 9 January 2020 at The University of Surrey, UK. Sixty people registered for the event, and all were invited to participate, either through chairing a session, presenting a ‘3 min lightning talk’ or by presenting a poster. The meeting consisted of an introduction to the topic by Dr Barbara Fielding, with presentations from eight invited speakers. There were also eight lightning talks and a poster session. The meeting aimed to highlight recent research that has used stable isotope tracer techniques to understand human metabolism. Such studies have irrefutably shaped our current understanding of metabolism and yet remain a mystery to many. The meeting aimed to de-mystify their use in nutrition research.

      AC Karmi, A Viljanen, R Borra, B Fielding, T Viljanen, K Frayn, P Iozzo, P Nuutila (2009)The effect of weight loss on intra-abdominal fatty acid metabolism in metabolic syndrome, In: DIABETOLOGIA52pp. S75-S75
      NY Loh, MJ Neville, K Marinou, SA Hardcastle, BA Fielding, EL Duncan, MI McCarthy, JH Tobias, CL Gregson, F Karpe, C Christodoulides (2015)LRP5 Regulates Human Body Fat Distribution by Modulating Adipose Progenitor Biology in a Dose- and Depot-Specific Fashion, In: CELL METABOLISM21(2)pp. 262-272 CELL PRESS
      C Fernandez, M Lindholm, M Krogh, S Lucas, S Larsson, P Osmark, K Berger, J Boren, B Fielding, K Frayn, C Holm (2008)Disturbed cholesterol homeostasis in hormone-sensitive lipase-null mice, In: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM295(4)pp. E820-E831 AMER PHYSIOLOGICAL SOC
      KH Hart, L Boyle, CA Hartwick, L Moreno, SA Lanham-New, B Fielding (2015)Live, eat, sleep football? Body size and composition and beliefs about physical activity in an international cohort of school-aged boys participating in regular team sport, In: PROCEEDINGS OF THE NUTRITION SOCIETY74(OCE1)pp. E97-E97 CAMBRIDGE UNIV PRESS
      U Riserus, D Sprecher, T Jonson, E Olson, S Hirschberg, Z Fang, P Hegde, D Richards, L Sarov-Blat, J Strum, J Cheeseman, B Fielding, N Moore, P Murgatroyd, S O'Rahilly, P Sutton, T Willson, D Hassall, F Keith, F Karpe (2007)PPAR-delta activation reverses multiple metabolic abnormalities, reduces oxidative stress and promotes fat oxidation in obese humans, In: INTERNATIONAL JOURNAL OF OBESITY31(9)pp. 1487-1487
      Martin B Whyte, Fariba Shojaee-Moradie, Sharaf E Sharaf, Nicola Jackson, Barbara Fielding, Roman Hovorka, Jeewaka Mendis, David Russell-Jones, A Margot Umpleby (2018)Lixisenatide reduces chylomicron triacylglycerol due to increased clearance, In: The Journal of Clinical Endocrinology & Metabolism104(2)pp. 359-368 Oxford University Press (OUP)

      Context GLP-1 agonists control postprandial glucose and lipid excursion in type 2 diabetes; however the mechanism(s) are unclear. Objective To determine the mechanism(s) of postprandial lipid and glucose control with lixisenatide (GLP-1 analogue) in type 2 diabetes. Design Randomised, double-blind, cross-over study. Setting Centre for Diabetes, Endocrinology, and Research, Royal Surrey County Hospital, Guildford, UK Patients Eight obese men with type 2 diabetes (57.3±1.9yrs; BMI 30.3±1.0kg/m2, HbA1C 66.5±2.6mmol/mol, [8.2±0.3%]). Interventions Two metabolic studies, four-weeks after lixisenatide or placebo; with cross-over and repetition of studies. Main outcome measures Study one: very-low density lipoprotein (VLDL) and chylomicron (CM) triacylglycerol (TAG) kinetics were measured with iv bolus of [2H5]glycerol in a 12h study, with hourly feeding. Oral [13C]triolein, in a single meal, labelled enterally-derived TAG. Study two: glucose kinetics were measured with [U-13C]glucose in a mixed-meal (plus acetaminophen to measure gastric emptying) and variable iv [6,6-2H2]glucose infusion. Results Study one: CM-TAG (but not VLDL-TAG) pool-size, was lower with lixisenatide (P=0.046). Lixisenatide reduced CM [13C]oleate AUC60-480min concentration (P=0.048) and increased CM-TAG clearance; with no effect on CM-TAG production rate. Study two: postprandial glucose and insulin AUC0-240min were reduced with lixisenatide (P=0.0051, P˂0.05). Total glucose production rate (Ra) (P=0.015), Rameal (P=0.0098) and acetaminophen AUC0-360min (P=0.006) were lower with lixisenatide than placebo. Conclusions Lixisenatide reduced [13C]oleate concentration, derived from a single meal in CM-TAG, as well as glucose Rameal, through delayed gastric emptying. However day-long CM production, measured with repeated meal-feeding, was not reduced by lixisenatide and decreased CM-TAG concentration was due to increased CM-TAG clearance.

      JB Moore, PJ Gunn, BA Fielding (2014)The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease, In: NUTRIENTS6(12)pp. 5679-5703 MDPI AG
      Fredrik Rosqvist, Catriona A McNeil, Camilla Pramfalk, Sion A Parry, Wee Suan Low, Thomas Cornfield, Barbara A Fielding, Leanne Hodson (2019)Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers, In: American Journal of Clinical Nutrition109(2)pp. 260-268 Oxford University Press (OUP)

      Background: Observational studies often infer hepatic de novo lipogenesis (DNL) by measuring circulating fatty acid (FA) markers; however it remains to be elucidated whether these markers accurately reflect hepatic DNL. Objective: We investigated associations between fasting hepatic DNL and proposed FA markers of DNL in subjects consuming their habitual diet. Design: Fasting hepatic DNL was assessed using ²H2O (heavy water) in 149 non-diabetic men and women and measuring the synthesis of very low-density lipoprotein triglyceride (VLDL-TG) palmitate. FA markers of blood lipid fractions was determined by gas chromatography (GC). Results: Neither the lipogenic index (16:0/18:2n-6) nor the SCD index (16:1n-7/16:0) in VLDL-TG were associated with isotopically assessed DNL (r=0.13, P=0.1 and r=-0.08, P=0.35, respectively). The relative abundance (mol%) of 14:0, 16:0 and 18:0 in VLDL-TG were weakly (r≤0.35) associated with DNL whereas abundance of 16:1n-7, 18:1n-7 and 18:1n-9 were not associated. When the cohort was split by median DNL, only abundance of 14:0 and 18:0 in VLDL-TG could discriminate between subjects having high (11.5%) and low (3.8%) fasting hepatic DNL. Based on a subgroup, FA markers in total plasma TG, plasma cholesteryl esters, plasma phospholipids and red blood cell phospholipids were generally not associated with DNL. Conclusions: The usefulness of circulating FAs as markers of hepatic DNL in healthy individuals consuming their habitual diet is limited due to their inability to clearly discriminate between individuals with low and high fasting hepatic DNL.

      GD Tan, MJ Neville, E Liverani, SM Humphreys, JM Currie, L Dennis, BA Fielding, F Karpe (2006)The in vivo effects of the Pro12Ala PPAR gamma 2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank, In: DIABETOLOGIA49(1)pp. 158-168 SPRINGER
      JL Ardilouze, F Karpe, JM Currie, KN Frayn, BA Fielding (2004)Subcutaneous adipose tissue blood flow varies between superior and inferior levels of the anterior abdominal wall, In: INTERNATIONAL JOURNAL OF OBESITY28(2)pp. 228-233 NATURE PUBLISHING GROUP
      C Fernandez, K Schuhmann, R Herzog, B Fielding, K Frayn, A Shevchenko, P James, C Holm, K Strom (2011)Altered Desaturation and Elongation of Fatty Acids in Hormone-Sensitive Lipase Null Mice, In: PLOS ONE6(6)ARTN e2160 PUBLIC LIBRARY SCIENCE
      L Hodson, R Banerjee, J Cheeseman, F Karpe, BA Fielding (2011)A large waist circumference is associated with higher liver fat in healthy pre-menopausal women in the absence of classical biochemical risk factors for CVD, In: PROCEEDINGS OF THE NUTRITION SOCIETY70(OCE4)pp. E229-E229 CAMBRIDGE UNIV PRESS
      AST Bickerton, R Roberts, BA Fielding, L Hodson, EE Blaak, AJM Wagenmakers, M Gilbert, F Karpe, KN Frayn (2007)Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period, In: DIABETES56(1)pp. 168-176 AMER DIABETES ASSOC
      KN Frayn, F Karpe, BA Fielding, IA Macdonald, SW Coppack (2003)Integrative physiology of human adipose tissue, In: INTERNATIONAL JOURNAL OF OBESITY27(8)pp. 875-888 NATURE PUBLISHING GROUP
      L Hodson, BA Fielding, A Bickerton, R Roberts, RW Milne, KN Frayn, E Karpe (2005)Incorporation of exogenous and endogenous fatty acids into very low-density lipoprotein (VLDL): a study using stable isotope and immunoaffinity techniques in humans, In: DIABETOLOGIA48pp. A233-A233
      AG DAVIES, RJ POSTLETHWAITE, DA PRICE, JL BURN, CA HOULTON, BA FIELDING (1984)URINARY ALBUMIN EXCRETION IN SCHOOL-CHILDREN, In: ARCHIVES OF DISEASE IN CHILDHOOD59(7)pp. 625-630 BRITISH MED JOURNAL PUBL GROUP
      BA Fielding, JS Samra, CL Ravell, KN Frayn (1999)Metabolism of individual fatty acids during infusion of a triacylglycerol emulsion, In: LIPIDS34(6)pp. 535-541 AMER OIL CHEMISTS SOC A O C S PRESS
      KN Frayn, BA Fielding, IA Macdonald, SW Coppack, V Lawrence, F Karpe (2004)Pulsatile blood flow and lipolysis in human adipose tissue, In: INTERNATIONAL JOURNAL OF OBESITY28pp. S81-S81
      R Roberts, A Bickerton, BA Fielding, E Blaak, AJM Wagenmakers, M Gilbert, F Karpe, KN Frayn (2004)A new protocol to study fatty acid metabolism in muscle and adipose tissue in subjects with the metabolic syndrome, In: INTERNATIONAL JOURNAL OF OBESITY28pp. S165-S165
      R Banerjee, BF Rial, J Suttie, A Lewandowski, MD Robson, J Schneider, L Hodson, B Fielding, JD Collier, E Barnes, S Neubauer (2012)WAIST CIRCUMFERENCE GREATER THAN 90CM IS A RISK FACTOR FOR HEPATIC STEATOSIS IN OTHERWISE HEALTHY ADULTS - A 3 TESLA MAGNETIC RESONANCE SPECTROSCOPY STUDY, In: JOURNAL OF HEPATOLOGY56pp. S504-S504
      BA Fielding, KN Frayn (2004)Lipid metabolism, In: CURRENT OPINION IN LIPIDOLOGY15(4)pp. 483-485 LIPPINCOTT WILLIAMS & WILKINS
      BA Fielding, R Roberts, A Bickerton, F Karpe, M Gilbert, KN Frayn (2004)Comparison of GC-MS and GC-cIRMS for the measurement of [C-13] palmitate enrichment in a stable isotope study in vivo in man, In: INTERNATIONAL JOURNAL OF OBESITY28pp. S165-S165
      LKM Summers, BA Fielding, SL Herd, V Ilic, ML Clark, PT Quinlan, KN Frayn (1999)Use of structured triacylglycerols containing predominantly stearic and oleic acids to probe early events in metabolic processing of dietary fat, In: JOURNAL OF LIPID RESEARCH40(10)pp. 1890-1898 LIPID RESEARCH INC
      L Egli, F Theytaz, V Campos, L Hodson, P Schneiter, B Fielding, L Tappy (2010)Exercise Prevents Fructose-Induced Hypertriglyceridemia in Healthy Young Males, In: FASEB JOURNAL24 FEDERATION AMER SOC EXP BIOL
      AST Bickerton, R Roberts, BA Fielding, E Blaakl, AJM Wagenmakers, M Gilbert, E Karpel, KN Frayn (2005)Adipose tissue fatty acid metabolism and the metabolic syndrome, In: DIABETOLOGIA48pp. A231-A232
      BA Fielding, KN Frayn (1998)Lipoprotein lipase and the disposition of dietary fatty acids, In: BRITISH JOURNAL OF NUTRITION80(6)pp. 495-502 C A B INTERNATIONAL
      JB Moore, BA Fielding (2016)Sugar and metabolic health: is there still a debate?, In: Current Opinion in Clinical Nutrition and Metabolic Care19(4)pp. 303-309

      Purpose of review: There is considerable political and public awareness of new recommendations to reduce sugars and sugar-sweetened beverages in our diets. It is therefore timely to review the most recent changes in guidelines, with a focus on evidence for metabolic health, recent research in the area and gaps in our knowledge. Recent findings: Sufficient evidence links a high intake of sugar to dental caries and obesity, and high intakes of sugar-sweetened beverages in particular to increased risk of type 2 diabetes. This has led to the updating of dietary recommendations related to added sugars in the diet. The effects of specific sugars at usual intakes as part of an isoenergetic diet are less clear. The glycaemic response to food is complex and mediated by many factors, but sugar intake is not necessarily the major component. Summary: There are many challenges faced by healthcare professionals and government bodies in order to improve the health of individuals and nations through evidence-based diets. Sufficiently powered long-term mechanistic studies are still required to provide evidence for the effects of reducing dietary sugars on metabolic health. However, there are many challenges for research scientists in the implementation of these studies.

      BA Fielding, L Hodson, R Roberts, A Bickerton, E Karpe, KN Frayn (2005)Use of a stable isotope technique to estimate postprandial chylomicron triacylglycerol concentrations without physical separation of the particles, In: DIABETOLOGIA48pp. A197-A197
      P Costet, E Ehrenborg, R Fisher, B Fielding, A Groen, D Kardassis, E Malle, M Mulder, A Niemeier, GD Norata, AT Hansen, AV Eckardstein (2012)European Lipoprotein Club: Report of the 35th ELC Annual Conference (Tutzing, 10th-13th September 2012), In: Atherosclerosis
      Simon Steenson, Fariba Shojaee-Moradie, Martin Whyte, Kim G. Jackson, Julie A. Lovegrove, Barbara Fielding, Margot Umpleby (2020)The effect of fructose feeding on intestinal triacylglycerol production and de novo fatty acid synthesis in humans, In: Nutrients MDPI

      A high fructose intake exacerbates postprandial plasma triacylglycerol (TAG) concentration, an independent risk factor for cardiovascular disease, although it is unclear whether this is due to increased production or impaired clearance of triacylglycerol (TAG)-rich lipoproteins. We determined the in vivo acute effect of fructose on postprandial intestinal and hepatic lipoprotein TAG kinetics and de novo lipogenesis (DNL). Five overweight men were studied twice, 4 weeks apart. They consumed hourly mixed-nutrient drinks that were high-fructose (30% energy) or low-fructose (

      LKM Summers, BA Fielding, V Ilic, PT Quinlan, KN Frayn (1998)The effect of triacylglycerol fatty acid positional distribution on postprandial metabolism in subcutaneous adipose tissue, In: BRITISH JOURNAL OF NUTRITION79(2)pp. 141-147 C A B INTERNATIONAL
      K Evans, PJ Kuusela, ML Cruz, I Wilhelmova, BA Fielding, KN Frayn (1998)Rapid chylomicron appearance following sequential meals: effects of second meal composition, In: BRITISH JOURNAL OF NUTRITION79(5)pp. 425-429 C A B INTERNATIONAL
      BA Fielding, G Reid, M Grady, SM Humphreys, K Evans, KN Frayn (2000)Ethanol with a mixed meal increases postprandial triacylglycerol but decreases postprandial non-esterified fatty acid concentrations, In: BRITISH JOURNAL OF NUTRITION83(6)pp. 597-604 C A B INTERNATIONAL
      LKM Summers, SC Barnes, BA Fielding, C Beysen, V Ilic, SM Humphreys, KN Frayn (2000)Uptake of individual fatty acids into adipose tissue in relation to their presence in the diet, In: AMERICAN JOURNAL OF CLINICAL NUTRITION71(6)pp. 1470-1477 AMER SOC CLINICAL NUTRITION
      A Ahmad, C Isherwood, BA Fielding, JD Bell, EL Thomas, G Frost, F Shojaee-Moradie, M Umpleby, BA Griffin (2012)Individuals with moderately raised liver fat show a greater increase in liver fat in response to a high sugar diet, In: PROCEEDINGS OF THE NUTRITION SOCIETY71(OCE2)pp. E31-E31 CAMBRIDGE UNIV PRESS
      MD Robertson, KG Jackson, CM Williams, BA Fielding, KN Frayn (2001)Prolonged effects of modified sham feeding on energy substrate mobilization, In: AMERICAN JOURNAL OF CLINICAL NUTRITION73(1)pp. 111-117 AMER SOC CLINICAL NUTRITION
      Simon R. Lord, Jennifer M. Collins, Wei-Chen Cheng, Syed Haider, Simon Wigfield, Edoardo Gaude, Barbara Fielding, Katherine E. Pinnick, Ulrike Harjes, Ashvina Segaran, Pooja Jha, Gerald Hoefler, Michael N. Pollak, Alastair M. Thompson, Pankaj G. Roy, Ruth. English, Rosie F. Adams, Christian Frezza, Francesca M. Buffa, Fredrik Karpe, Adrian L. Harris (2020)Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin, In: British Journal of Cancer122(2)pp. 258-265 Nature

      Background Epidemiological studies suggest that metformin may reduce the incidence of cancer in patients with diabetes and multiple late phase clinical trials assessing the potential of repurposing this drug are underway. Transcriptomic profiling of tumour samples is an excellent tool to understand drug bioactivity, identify candidate biomarkers and assess for mechanisms of resistance to therapy. Methods Thirty-six patients with untreated primary breast cancer were recruited to a window study and transcriptomic profiling of tumour samples carried out before and after metformin treatment. Results Multiple genes that regulate fatty acid oxidation were upregulated at the transcriptomic level and there was a differential change in expression between two previously identified cohorts of patients with distinct metabolic responses. Increase in expression of a mitochondrial fatty oxidation gene composite signature correlated with change in a proliferation gene signature. In vitro assays showed that, in contrast to previous studies in models of normal cells, metformin reduces fatty acid oxidation with a subsequent accumulation of intracellular triglyceride, independent of AMPK activation. Conclusions We propose that metformin at clinical doses targets fatty acid oxidation in cancer cells with implications for patient selection and drug combinations. Clinical Trial Registration NCT01266486.

      M Bucci, AC Karmi, P Iozzo, BA Fielding, A Viljanen, RM Badeau, R Borra, V Saunavaara, T Pham, JC Hannukainen, K Kalliokoski, M Haaparanta-Solin, T Viljanen, R Parkkola, KN Frayn, P Nuutila (2015)Enhanced fatty acid uptake in visceral adipose tissue is not reversed by weight loss in obese individuals with the metabolic syndrome, In: DIABETOLOGIA58(1)pp. 158-164 SPRINGER
      KG Jackson, MD Robertson, BA Fielding, KN Frayn, CM Williams (2001)Second meal effect: modified sham feeding does not provoke the release of stored triacylglycerol from a previous high-fat meal, In: BRITISH JOURNAL OF NUTRITION85(2)pp. 149-156 C A B INTERNATIONAL
      MC Nydahl, RD Smith, CNM Kelly, BA Fielding, CM Williams (2003)Achievement of dietary fatty acid intakes in long-term controlled intervention studies: approach and methodology, In: PUBLIC HEALTH NUTRITION6(1)pp. 31-40 C A B I PUBLISHING
      Roselle A. Herring, Fariba Shojaee-Moradie, Robert Garesse, Mary Stevenage, Nicola Jackson, Barbara Fielding, Agampodi Mendis, Sigurd Johnsen, Margot Umpleby, Melanie Davies, David L. Russell-Jones (2020)Full Title Metabolic effects of an SGLT2 inhibitor (dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes., In: Diabetes Care American Diabetes Association

      Objective: To determine the effect of SGLT2 inhibitor dapagliflozin on glucose flux, lipolysis and ketone body concentrations during insulin withdrawal in people with type 1 diabetes. Research Design and Methods: A double-blind placebo controlled crossover study with a 4-week wash out period was performed in 12 people with type 1 diabetes using insulin pump therapy. Participants received dapagliflozin or placebo in random order for 7 days. Stable isotopes were infused to measure the rate of glucose production (Ra), disappearance (Rd) and lipolysis. At isotopic steady state insulin was withdrawn and the study terminated after 600 minutes or earlier if blood glucose reached 18mmol/L, bicarbonate 27 and

      BA Fielding, KN Frayn (2000)Lipid metabolism - Editorial comment, In: CURRENT OPINION IN LIPIDOLOGY11(6)pp. 657-659 LIPPINCOTT WILLIAMS & WILKINS
      KG Jackson, MD Robertson, BA Fielding, KN Frayn, CM Williams (2002)Olive oil increases the number of triacylglycerol-rich chylomicron particles compared with other oils: an effect retained when a second standard meal is fed, In: AMERICAN JOURNAL OF CLINICAL NUTRITION76(5)pp. 942-949 AMER SOC CLINICAL NUTRITION
      D Kalant, S Phelis, BA Fielding, KN Frayn, K Cianflone, AD Sniderman (2000)Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women, In: JOURNAL OF LIPID RESEARCH41(12)pp. 1963-1968 LIPID RESEARCH INC
      Pooja Agarwal, Theo Combes, Fariba Shojace-Moradie, Barbara Fielding, Simon Gordon, Valerie Mizrahi (2020)Foam Cells Control Mycobacterium tuberculosis Infection, In: Frontiers in Microbiology111394 Frontiers Media

      Mycobacterium tuberculosis (Mtb) infects macrophages and macrophage-derived foam cells, a hallmark of granulomata in tuberculous lesions. We analysed the effects of lipid accumulation in human primary macrophages and quantified strong triglyceride and phospholipid remodelling which depended on the dietary fatty acid used for the assay. The enrichment of >70% in triglyceride and phospholipids can alter cell membrane properties, signalling and phagocytosis in macrophages. In conventional macrophage cultures, cells are heterogeneous, small or large macrophages. In foam cells, a third population of 30% of cells with increased granularity can be detected. We found that foam cell formation is heterogenous and that lipid accumulation and foam cell formation reduces the phagocytosis of Mtb. Under the conditions tested, cell death was highly prevalent in macrophages, whereas foam cells were largely protected from this effect. Foam cells also supported slower Mtb replication, yet this had no discernible impact on the intracellular efficacy of four different antitubercular drugs. Foam cell formation had a significant impact in the inflammatory potential of the cells. TNF-α, IL-1β and prototypical chemokines were increased. The ratio of inflammatory IL-1β, TNF-α and IL-6 versus anti-inflammatory IL-10 was significantly higher in response to Mtb versus LPS, and was increased in foam cells compared to macrophages, suggestive of increased pro-inflammatory properties. Cytokine production correlated with NF-κB activation in our models. We conclude that foam cell formation reduces the host cell avidity for, and phagocytosis of, Mtb while protecting the cells from death. This protective effect is associated with enhanced inflammatory potential of foam cells and restricted intracellular growth of Mtb.

      HE Moher, G Tan, BA Fielding, GB Carey (2001)Arterio-venous (AV) difference of cyclic adenosine monophosphate (cAMP) serosa human adipose tissue in vivo, In: FASEB JOURNAL15(4)pp. A299-A299 FEDERATION AMER SOC EXP BIOL
      BA Fielding, R Banerjee, B Rial (2015)Menopausal status and abdominal obesity are significant determinants of hepatic lipid metabolism in women, In: Journal of the American Heart Association4 Wiley

      Background Android fat distribution (abdominal obesity) is associated with insulin resistance, hepatic steatosis and greater secretion of large very low density lipoprotein (VLDL) particles in men. Since abdominal obesity is becoming increasingly prevalent in women we aimed to investigate the relationship between android fat and hepatic lipid metabolism in pre- and post-menopausal women. Methods and Results We used a combination of stable isotope tracer techniques to investigate intrahepatic fatty acid synthesis and partitioning in 29 lean and 29 abdominally obese women (android fat/total fat 0.065 (0.02-0.08) and 0.095 (0.08-0.11) respectively). Thirty women were pre-menopausal aged 35-45 and they were matched for abdominal obesity with 28 post-menopausal women aged 55-65. As anticipated, abdominal obese women were more insulin resistant with enhanced hepatic secretion of large (404±30 v 268±26 mg/kg lean mass, P

      Tracey Robertson, Jonathan Brown, Barbara Fielding, M. Denise Robertson (2020)The cumulative effects of chilling and reheating a carbohydrate-based pasta meal on the postprandial glycaemic response: a pilot study, In: European Journal of Clinical Nutrition Springer Nature

      This pilot study investigated the effects of chilling and reheating a pasta-based meal on the postprandial glycaemic response. In this single-blind crossover study, 10 healthy volunteers consumed identical pasta meals (pasta, olive oil and tomato sauce), served either freshly prepared, chilled or chilled/reheated, on three separate randomised occasions. Capillary blood samples were taken for two hours postprandially. A significant difference in glucose Incremental Area Under the Curve (IAUC) was observed (p = 0.006), with the greatest difference observed between the freshly cooked and chilled/reheated meals (p = 0.041). Significant differences in incremental peak glucose were also observed (p = 0.018). These results suggest that making simple changes to domestic food processing methods can reduce the glycaemic excursion following a pasta meal, with the potential for health benefit.

      L Hodson, T Ruge, R Milne, BA Fielding, KN Frayn, F Karpe (2006)Dietary fat is a major contributor to VLDL production in the fed state in humans, In: ATHEROSCLEROSIS188(1)pp. S3-S4
      E Gutierrez, D Wiggins, B Fielding, AP Gould (2007)Specialized hepatocyte-like cells regulate Drosophila lipid metabolism, In: NATURE445(7125)pp. 275-280 NATURE PUBLISHING GROUP
      F Theytaz, Y Noguchi, L Egli, V Campos, T Buehler, L Hodson, BW Patterson, N Nishikata, R Kreis, B Mittendorfer, B Fielding, C Boesch, L Tappy (2012)Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans, In: AMERICAN JOURNAL OF CLINICAL NUTRITION96(5)pp. 1008-1016 AMER SOC NUTRITION-ASN
      BA Fielding, SM Humphreys, RF Allman, KN Frayn (1993)Mono-, di- and triacylglycerol concentrations in human plasma: effects of heparin injection and of a high-fat meal., In: Clin Chim Acta216(1-2)pp. 167-173

      A sensitive method has been developed to measure specific mono-, di- and triacylglycerol concentrations in human plasma, using thin-layer chromatography and enzymatic assay. The levels of partial acylglycerols in human plasma from fasting subjects were lower than previous reports had suggested and amounted to less than 3% of the total acylglycerols. After heparin injection the plasma monoacylglycerol concentration increased markedly (P < 0.01) while the triacylglycerol concentration decreased significantly (P < 0.001). The plasma diacylglycerol concentration did not change significantly although it increased as a percentage of the total (P < 0.05); after heparin partial acylglycerols accounted for more than 10% of the total. After a high-fat meal the plasma concentrations of di- and triacylglycerol increased approximately two-fold (P < 0.005) but no significant change was observed for mono-acylglycerol. The percentage contribution of partial acylglycerols was unchanged (2.6% fasting, 2.4% postprandially).

      K Marinou, L Hodson, KN Frayn, F Karpe, BA Fielding (2007)Sources of fatty acids for 3-hydroxybutyrate production differ during short-term fasting in men and women, In: ATHEROSCLEROSIS SUPPLEMENTS8(1)pp. 23-24
      F Karpe, A Bickerton, B Fielding, L Hodson, T Ruge, K Frayn (2007)Abnormalities in fatty acid storage and delivery in the metabolic syndrome, In: INTERNATIONAL JOURNAL OF OBESITY31pp. S6-S6
      R Roberts, A Bickerton, BA Fielding, E Blaak, AJM Wagenmakers, M Gilbert, F Karpe, KN Frayn (2006)Reduced oxidation of dietary fat after a short term high-carbohydrate diet, In: ATHEROSCLEROSIS188(1)pp. S3-S3
      MFF Chong, BA Fielding, KN Frayn (2007)Metabolic interaction of dietary sugars and plasma lipids with a focus on mechanisms and de novo lipogenesis, In: PROCEEDINGS OF THE NUTRITION SOCIETY66(1)pp. 52-59 CAMBRIDGE UNIV PRESS
      Simon R. Lord, Jennifer M. Collins, Wei-Chen Cheng, Syed Haider, Simon Wigfield, Edoardo Gaude, Barbara A. Fielding, Katherine E. Pinnick, Ulrike Harjes, Ashvina Segaran, Pooja Jha, Gerald Hoefler, Michael N. Pollak, Alastair M. Thompson, Pankaj G. Roy, Ruth English, Rosie F. Adams Adams, Christian Frezza, Francesca M. Buffa, Fredrik Karpe, Adrian L. Harris (2019)Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin, In: British Journal of Cancer Springer Nature

      Background: Epidemiological studies suggest that metformin may reduce the incidence of cancer in patients with diabetes and multiple late phase clinical trials assessing the potential of repurposing this drug are underway. Transcriptomic profiling of tumour samples is an excellent tool to understand drug bioactivity, identify candidate biomarkers and assess for mechanisms of resistance to therapy. Methods: 36 patients with untreated primary breast cancer were recruited to a window study and transcriptomic profiling of tumour samples carried out before and after metformin treatment. Results: Multiple genes that regulate fatty acid oxidation were upregulated at the transcriptomic level and there was a differential change in expression between 2 previously identified cohorts of patients with distinct metabolic responses. Increase in expression of a mitochondrial fatty oxidation gene composite signature correlated with change in a proliferation gene signature. In vitro assays showed that, in contrast to previous studies in models of normal cells, metformin reduces fatty acid oxidation with a subsequent accumulation of intracellular triglyceride, independent of AMPK activation. Conclusions: We propose that metformin at clinical doses targets fatty acid oxidation in cancer cells with implications for patient selection and drug combinations.

      KN FRAYN, S SHADID, R HAMLANI, SM HUMPHREYS, ML CLARK, BA FIELDING, O BOLAND, SW COPPACK (1994)REGULATION OF FATTY-ACID MOVEMENT IN HUMAN ADIPOSE-TISSUE IN THE POSTABSORPTIVE-TO-POSTPRANDIAL TRANSITION, In: AMERICAN JOURNAL OF PHYSIOLOGY266(3)pp. E308-E317 AMER PHYSIOLOGICAL SOC
      H DHAR, BA FIELDING, ML CLARK, KN FRAYN (1990)BACKGROUND TURBIDITY CHANGES DURING THE ESTIMATION OF URINARY ALBUMIN, In: ANNALS OF CLINICAL BIOCHEMISTRY27pp. 161-162 ROYAL SOC MEDICINE SERVICES LTD
      K Sevastianova, A Santos, A Kotronen, A Hakkarainen, J Makkonen, K Silander, M Peltonen, S Romeo, J Lundbom, N Lundbom, VM Olkkonen, H Gylling, BA Fielding, A Rissanen, H Yki-Jarvinen (2012)Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans, In: AMERICAN JOURNAL OF CLINICAL NUTRITION96(4)pp. 727-734 AMER SOC NUTRITION-ASN